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E-mail address: sophie.malagarie@uah.es (S. MalagIn this study, capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) induced an increase in the cell
viability of the androgen-responsive prostate cancer LNCaP cells, which was reversed by the use
of the TRPV1 antagonists capsazepine, I-RTX and SB 366791. In further studies we observed that cap-
saicin induced a decrease in ceramide levels as well as Akt and Erk activation. To investigate the
mechanism of capsaicin action we measured androgen (AR) receptor levels. Capsaicin induced an
increase in the AR expression that was reverted by the three TRPV1 antagonists. AR silencing by
the use of siRNA, as well as blocking the AR receptor with bicalutamide, inhibited the proliferative
effect of capsaicin.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is a highly
potent active ingredient of hot red and chilli peppers that belong to
the plant genus Capsicum (Solanaceae) [1,2]. It has been found to
act on the capsaicin-sensitive afferent nerves and it has been
extensively studied in vivo and in vitro for the treatment of mi-
graine, chronic cough, overactive bladder and diabetes [3,4] and
as a potent analgesic [5,6] and anti-cancer agent [7]. Many of the
capsaicin actions are mediated by the transient receptor potential
vanilloid 1 (TRPV1) receptor, which is a non-selective membrane
cation channel that is activated not only by capsaicin but also by
noxious heat, acid and by recently described endogenous lipids
[8]. Numerous investigations have been conducted to determine
the role of capsaicin and TRPV1 in cell proliferation, but the results
are conﬂicting. Many studies have reported that capsaicin exerts
anti-cancer effects by causing cell cycle arrest and inducing apop-
tosis in vitro in many different human cancers [9–11]. The involve-
ment of TRPV1 in such anti-proliferative effects of capsaicin has
not always been demonstrated, and in most cases, capsaicin in-
duces apoptosis by a receptor-independent mechanism [12]. In
contrast, capsaicin has been shown to signiﬁcantly reduce liver in-
jury and hepatic apoptosis [13] and to increase DNA synthesis
in vitro [14]. The effect elicited by capsaicin may depend on cellchemical Societies. Published by E
arie-Cazenave).type, doses used [14] as well as the length of the treatment.
Long-term treatments of rodents with capsaicin beyond 90 days,
as well as high doses, have been shown to be toxic and potentially
carcinogenic [15,16] whereas small amounts of capsaicin display
few or no deleterious effects [16]. In previous studies, our group
has demonstrated the role of capsaicin against the androgen-inde-
pendent prostate cancer cell line PC-3 in vitro and in vivo [17,18].
The anti-proliferative effect of capsaicin in PC-3 cells was receptor-
independent and mediated by de novo synthesis of ceramides [18].
However, the effect of capsaicin in androgen-sensitive prostate
cells has not been studied before. Normal prostate cells have
androgen-dependent growth mediated by the androgen receptor
(AR), a ligand-mediated transcription factor that belongs to the
superfamily of steroid receptors [19]. At initial stages, prostate
cancer cells depend on androgens for growth and therefore andro-
gen pathway blockage is the standard therapy for the treatment of
prostate cancers. However, in spite of initial sensitivity, prostate
cancers move more or less quickly towards an androgen-indepen-
dent stage characterized by resistance to such therapy. It is there-
fore essential to understand what drives the progression to
androgen-independence and identify the molecular markers for
both the early androgen-dependent and the advanced androgen-
independent prostate cancer stages.
In this study, we investigated the effect of capsaicin on prolifer-
ation and signaling pathways of prostate androgen-sensitive
LNCaP cells. We found that capsaicin induced an increase in cell
viability through TRPV1, PI3K/Akt, ERK and AR activation.lsevier B.V. All rights reserved.
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Fig. 1. Capsaicin effects on cell viability. LNCaP cells were incubated with various
doses of capsaicin (CAP) in the presence or absence of 1 lM of the TRPV1 antagonist
capsazepine (CPZ). (A) Cell viability was assessed by MTT test. (B) Effect of different
TRPV1 antagonists (1 lM CPZ; 10 lM SB 366791; 100 nM I-RTX) and TRPM8
agonist (icilin, 10 lM IC) on capsaicin-induced cell viability. (C) Ceramide levels
were determined using diacylglycerol kinase and are expressed as a percentage of
the value observed before treatment. The P-values for statistical analyzes calculated
by Student’s t-test are: *P < 0.01; **P < 0.05.
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2.1. Reagents
Capsaicin and capsazepine were purchased from Tocris (Bristol,
UK). The antagonist SB 366791 was from Sigma (St. Louis, MO,
USA) and I-RTX from Alexix (Grünberg, Germany). Bisindolylmale-
imide (BIM), Fumonisin B1 and PD 98059 were obtained from Cal-
biochem (Darmstadt, Germany). LY-294,002 was purchased from
Alexis (Grünberg, Germany). Bicalutamide was kindly provided
by AstraZeneca (Cheshire, UK). Anti-phospho-p42/44 MAP Kinase
and Phospho-Akt (Thr308) were purchased from Cell Signaling
Technology (Beverley, MA, USA), and anti-phospho-ERK (E-4),
anti-phospho-STAT3 and STAT3 from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-human androgen receptor monoclonal
antibody was supplied by Becton Dickinson Biosciences (Erem-
bodegem, Belgium). Other products were from Sigma (St. Louis,
MO, USA).
2.1.1. Cell culture
Lymph node carcinoma of the prostate (LNCaP) cells were pur-
chased from ATCC (CRL-1740) and were cultured as previously de-
scribed [17]. LNCaP cells from between the 5th and the 25th
passage in vitro were used to conduct the studies.
2.1.2. Cell viability assays
Cells were plated in 24-well plates at 20000 cells per well.
Prostate cells were treated with the indicated stimuli and
further incubated at 37 C for 48 h. Cell viability was estimated
directly on culture plates by MTT assay (Sigma, St. Louis, MO,
USA).
2.1.3. Lipid extraction and analysis
Cell pellets were resuspended in 0.6 ml distilled water, and dis-
rupted at 4 C by brief sonication. Lipids were extracted with chlo-
roform/methanol and ceramide content was determined using
E. coli diacylglycerol kinase (Calbiochem, Darmstadt, Germany)
and [32P]c-ATP (6000 Ci/mmol; Perkin–Elmer, Barcelona) as
previously reported [20]. Radioactive ceramide-1-phosphate was
isolated by thin-layer chromatography using chloroform/acetone/
methanol/acetic acid/water (50:20:15:10:5, by volume) as the
developing solvent. Products of this reaction were quantiﬁed
and expressed as a percentage of the value observed before
treatment.
2.1.4. Western-blot analysis
Cultured cells were lysed into a lysis buffer (50 mM Tris–HCl,
pH 7.4, 5 mM EDTA, 1 mM EGTA, 10 mM b-mercaptoethanol) con-
taining 5 lg/ml leupeptin, 5 lg/ml aprotinin and 1 mM phenyl-
methylsulfonyl ﬂuoride, and disrupted by sonication. Protein
concentration was determined using the Bio-Rad protein assay
(Bio-Rad laboratories, Hercules, CA). Western blotting was done
as previously described [17].
2.1.5. RNA silencing
LNCaP cells were transfected with siRNA duplexes correspond-
ing to human androgen receptor gene (50-UCCCCAAGCCAUCGUAG-
ATT-30, Invitrogen, Life Technologies Co., Carlsbad, CA). The
puriﬁed siRNA duplexes were transfected to the cells with the lipo-
fectamine reagent (Invitrogen Co., Carlsbad, CA), in MEM medium
as recommended by the manufacturer and the ﬁnal siRNA concen-
tration was 100 nM. 24 h after transfection, cells were placed into
fresh RPMI 1640 medium supplemented with 10% FBS. At the indi-
cated time points after transfection, cells were used for MTT assays
or Western blot.2.1.6. Statistical analysis
Data are presented as the mean ± S.D. of the number of experi-
ments indicated. Statistical comparisons among groups were made
with a Student’s t-test and the difference was considered to be sta-
tistically signiﬁcant when the P value was <0.05.
3. Results
3.1. Induction of LNCaP cell proliferation by capsaicin
We ﬁrst examined the effect of the prototypic vanilloid receptor
agonist, capsaicin, on the androgen-sensitive prostate cancer
LNCaP cell line and we found surprisingly that capsaicin caused a
concentration-dependent increase in cell viability (Fig. 1A). This
S. Malagarie-Cazenave et al. / FEBS Letters 583 (2009) 141–147 143effect was reversed by the vanilloid receptor antagonist, capsaze-
pine, at 1 lM (Fig. 1A), suggesting a receptor-dependent mecha-
nism. To conﬁrm the involvement of the TRPV1 receptor, we
used the compound SB 366791 which exhibits potent competitive
antagonistic activity in human receptors and has a better selective
proﬁle than capsazepine [21]. SB and I-RTX, a classical TRPV1
antagonist [21], inhibited the pro-survival effect induced by capsa-CAP
CPZ
P-p44/42 MAPK
p42 MAPK
Tubulin
P-Akt
0 1 µM
- +-
A
CAP
P-p44/42 MAPK
LY
p42 MAPK
Tubulin
P-Akt
0 1 µM
- +-
B
CAP
PD
P-p44/42 MAPK
p42 MAPK
Tubulin
P-Akt
0 1 µM
- +-
C
D
M
TT
 (%
 of
co
n
tr
o
l)
60%
0 1
80%
100%
120%
140%
160% CAP
LY
PD
*
*
*
Fig. 2. Activation of the PI3K and ERK pathways by capsaicin in LNCaP cells. Cells wer
capsazepine, 1 lM LY 294002 (LY) and 100 nM PD 98059 (PD). (A) Cell viability assesse
*P < 0.05. (B–D) Western blots for Akt, p44/42 MAPK, total MAPK and tubulin.icin, suggesting a receptor-dependent effect (Fig. 1B). Capsazepine
has also been described as a TRPM8 antagonist. To rule out the
involvement of the channel TRPM8, we used the speciﬁc and po-
tent TRPM8 agonist, icilin [22,23]. As shown in Fig. 1B, icilin did
not have any effect on LNCaP cell viability.
Results obtained with capsaicin in LNCaP cells contrasted with
our previous results showing receptor-independent cell death10 µM 20 µM
- -+ +
0
+
10 µM 20 µM
- -+ +
0
+
10 µM 20 µM
- -+ +
0
+
10 20
*
**
*
**
*
*
**
µM CAP
e incubated with indicated doses of capsaicin in the presence or absence of 1 lM
d by MTT test. The P-values for statistical analyzes calculated by Student’s t-test is
144 S. Malagarie-Cazenave et al. / FEBS Letters 583 (2009) 141–147promotion by capsaicin in androgen-insensitive PC-3 cells [17].
Therefore, in order to ascertain discrepancies obtained between
PC-3 cells and LNCaP cells, we analyzed different signaling
pathways.0%
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*P < 0.01; **P < 0.05.3.2. Capsaicin inhibits ceramide production
We have previously shown that capsaicin promotes prostate
PC-3 cell death through de novo synthesis of ceramide [18], so
we measured intracellular levels of ceramides in LNCaP cells trea-
ted with capsaicin. In concordance with the results obtained for
cell viability we found that capsaicin induced a dose-dependent
reduction of ceramide production (Fig. 1C). This effect was also
receptor-dependent, as conﬁrmed by the increase in ceramide pro-
duction when the inhibitor capsazepine was added (Fig. 1C).
3.3. Capsaicin activates PI3K and ERK pathways
To determine which mechanisms were activated by capsaicin,
additional experiments using various signaling pathway inhibitors
were performed. We observed a reversion of the capsaicin-induced
proliferation effect with the PI3K inhibitor LY 294002 (LY) at 1 lM,
and the MEK inhibitor PD 98059 (PD) at 100 nM (Fig. 2A). To cor-
roborate that PI3K and ERK kinases were activated by capsaicin
in LNCaP cells, we detected the phosphorylated forms of Akt and
44/42 MAPK, which are their respective downstream substrates.
The results show that capsaicin induced a dose-dependent increase
in the phosphorylated forms of Akt and p44/42 MAPK, which was
reverted by the antagonist capsazepine at 1 lM (Fig. 2B) To con-
ﬁrm PI3K and MEK activation and to elucidate the relationship be-
tween pathways, Western blots were performed in the presence of
the inhibitors LY and PD (Fig. 2C and D). As seen in Fig. 2C, Akt1 10 20
M CAP
*
*
*
*
**
10 µM 20 µM
-+ +
0
+
+
PD
++ +-
I-RTX
- -
SB
t of AR in cells incubated with the indicated doses of capsaicin in the presence or
aicin in the presence or absence of 1 lM LY294002 or 100 nM PD 98059, 10 lM SB
e or absence of 2 lM bicalutamide (BIC). The P-values for statistical analyzes are:
S. Malagarie-Cazenave et al. / FEBS Letters 583 (2009) 141–147 145phosphorylation was blocked by the PI3K inhibitor LY, conﬁrming
the activation of the PI3K pathway by capsaicin. However, p44/42
MAPK phosphorylation was not inhibited by LY, suggesting that
ERK pathway activation was not dependent on PI3K. In the same
way, p44/42 MAPK phosphorylation was blocked by the MEK
inhibitor, PD, whereas it was not modiﬁed by LY (Fig. 2D). This re-
sult suggests that activation of the PI3K and ERK pathways by cap-
saicin in LNCaP cells are independent phenomena that are
activated through the TRPV1 receptor.
To test whether the capsaicin-induced stimulation of ceramide
was dependent on PI3K or MEK activation, we preincubated LNCaP
cells with LY or PD at the concentrations used above. Fig. 3 shows
that pre-treatment of cells with both inhibitors reversed the capsa-
icin-induced decrease in intracellular ceramide. This effect was ob-
served at various doses of capsaicin, and suggests that capsaicin
activates PI3K and p44/42 MAPK pathways to inhibit ceramide
production and to induce increased cell viability.
3.4. Role of the androgen receptor
To gain some insight into the capsaicin-induced cell viability
increase taking place in LNCaP cells, we measured androgen
receptor (AR) levels using an immunoblot approach. The data
show that capsaicin induced a dose-dependent increase in AR,
which was consistent with its proliferative activity (Fig. 4A). The
induction of AR expression was mediated by the TRPV1 receptor,
as conﬁrmed by the inhibition by capsazepine at all the capsaicin
doses tested (Fig. 4A) and by SB 366791 and I-RTX (Fig. 4B). Both
the PI3K inhibitor LY and the MEK inhibitor PD reduced the in-M
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(A) Cell viability of LNCaP cells incubated with different doses of capsaicin in the
presence of 2 lM bicalutamide. (B) Cells were transfected with speciﬁc AR siRNA or
control scrambled RNA for 48 h followed by incubation with capsaicin for an
additional 48 h. Cell viability was then assayed by MTT. Insert, Western blot of AR in
cells transfected with siRNA or control scrambled RNA.crease in AR expression (Fig. 4B) suggesting that activation of
these signaling pathways occurred prior to androgen receptor
induction. To investigate the role of the androgen receptor in
the capsaicin-promoted cell viability increase, we incubated
LNCaP cells with capsaicin in the presence of the competitive AR
antagonist bicalutamide. The results shown in Fig. 5A indicate that
bicalutamide inhibits the increase in cell viability induced by
capsaicin.
To assess the role of AR in the proliferative action of capsaicin,
we silenced the expression of this receptor with small interfering
RNA (siRNA). An immunoblot experiment conﬁrmed that AR was
drastically suppressed after siRNA-AR transfection for 72 h, drop-
ping to 20 ± 7% of the control scrambled RNA detected in the Wes-
tern-blot assay (Fig. 5B, insert). In cells transfected with speciﬁc AR
siRNA, capsaicin did not induce an increase in cell viability, con-
ﬁrming that the AR receptor is essential for capsaicin-induced cell
proliferation in the androgen-sensitive LNCaP cells.4. Discussion
We have previously reported that the androgen-sensitive pros-
tate cancer LNCaP cell line expresses the TRPV1 receptor [24]. In
the present study capsaicin was found to increase the viability of
the androgen-sensitive LNCaP cell line in a TRPV1 receptor-depen-
dent way. We demonstrated that the proliferative action of capsa-
icin was concomitant with a reduction in intracellular ceramide
levels and was mediated by the PI3K/Akt and ERK pathways. The
reduction of ceramide levels by capsaicin is consistent with its ef-
fect on cell viability. The intracellular effects of ceramide are pleio-
tropic, but for the most part growth-inhibiting [25]. Besides,
reduction of ceramide levels has been reported to attenuate cell
death in several instances, probably due to its conversion into cer-
amide-1-phosphate, which is mitogenic. The mechanism whereby
capsaicin promotes a reduction in ceramide levels and its possible
metabolism into phosphorylated mediators was not tackled in this
study but will be approached in further research.
Activation of the PI3K and ERK pathways by capsaicin has pre-
viously been demonstrated to occur in dorsal root ganglion neuro-
nes [26] and in human hepatoma HepG2 cells [27] through
activation of the capsaicin receptor TRPV1. Recently, several
groups reported that Akt is involved in the pain hypersensitivity
induced by intradermal injection of capsaicin in rats [28–30]. In
prostate cells, activation of the PI3K pathways regulates the tran-
scriptional activity of the androgen receptor as well as its expres-
sion, cooperating with the AR in tumor development [31]. As the
vanilloid capsaicin-induced activation of the PI3K/Akt pathway,
we investigated whether capsaicin regulated AR expression and
activity in the androgen-responsive prostate LNCaP cell line. We
found that capsaicin induced a dose-dependent increase in AR
expression. Moreover, we demonstrated that capsaicin induced
its pro-survival effect through the AR receptor, since AR silencing
with siRNA reduced the effect of capsaicin. The fact that the AR
antagonist bicalutamide inhibited the pro-survival effect of capsa-
icin provides additional evidence that the effect of capsaicin is via
AR activation. Studies performed by Mori et al. [32] showed that
capsaicin inhibited the growth of LNCaP cells and the DHT-induced
expression of AR. However, the doses of capsaicin used in that
study were higher than ours and, as the authors pointed out, higher
than those needed to affect TRVP1. Also, overexpression of AR did
not affect the anti-proliferative effect of capsaicin, suggesting that
downregulation of AR was not the decisive mechanism of action
for capsaicin [32]. Since the proliferative effect of DHT in LNCaP
cells is so strong, there lies the possibility that the effect of capsa-
icin in the presence of DHT may be different to that of capsaicin
alone.
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the androgen-resistant prostate PC-3 cell line by a TRPV1-inde-
pendent pathway [17,18]. However, the involvement of TRPV1 in
cell growth inhibition in androgen-resistant prostate cells is far
from being elucidated. Melck et al. [33] showed that arvanil, a
structural hybrid between capsaicin and anandamide and an ago-
nist for both cannabinoid and TRPV1 receptors, inhibited the pro-
lactin-induced prostate DU-145 cell growth, which was blocked by
capsazepine. These results suggested a role for TRPV1 in the anti-
proliferative effect of arvanil on this androgen-resistant prostate
cell line. However, the effect of arvanil was only observed in the
presence of PRL and not alone [33]. Although the mechanism of
TRPV1 activation remains elusive, recent data suggest that it com-
plexes with the high afﬁnity neurotrophic receptor TrkA, which
regulates TRPV1 activity [34]. The effect of arvanil in prostate
DU-145 cells observed by Melck et al. could be due to the TrkA
down-regulation induced by arvanil and could explain the discrep-
ancies with our results. Also, the different effects of capsaicin on
cellular proliferation and on metabolic activities may be depen-
dent on dose, term of treatment, and the stage and androgen sen-
sitivity of the targeted prostate cell. The opposite effects on cell
proliferation induced by capsaicin in LNCaP cells and in PC-3 cells
can be explained if the action of capsaicin in prostate cells is
dependent on different signaling pathways and on androgen sen-
sitivity. This seems to be the case since in LNCaP cells the effect of
capsaicin is mediated by the TRPV1 and androgen receptor
whereas in PC-3 cells capsaicin induces apoptosis in a receptor-
independent way. The role of TRPV1 in LNCaP cells is not surpris-
ing and is common to other transient receptor potential (TRP)
receptor family members. It has previously been reported that
TRPV8 is expressed in LNCaP cells and that it is required for cell
survival [35]. Moreover, recent research demonstrated differential
TRPM8 localization and the functional dependence on AR activity
of human prostate epithelial cells and on their differentiation sta-
tus [36]. Our results highlight the importance of androgen sensi-
tivity in the response of prostate cancer cells to capsaicin. The
results have clinical relevance since TRPV1 desensitisation by
intravesical capsaicin administration is currently used for bladder
incontinence [37]. However, desensitisation may become obsolete
when non-toxic, potent TRPV1 antagonists become available. A
more thorough understanding of the mechanism of capsaicin ac-
tion could potentially lead to the development of new therapeutic
approaches not only for bladder disorders but also for prostate
cancer.
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